SREBF1 and breast cancer: To explore this hypothesis, we analyzed the genome-wide occupancy of SREBF1 in three different cell types, namely SCC (TE5 and KYSE150 cell lines), liver cancer (HepG2 cell line) and breast cancer (MCF7 cell line).